Answers are grounded in this paper and cite their sources.
The recurrent lesions disappeared 2 months after the first dose of pembrolizumab, and the patient remained in clinical remission at 1 year. To the best of our knowledge, there are no other reports of successful ICI therapy after HN-PIT.
No takes yet. Share an insight, caveat, or question.
Hanyu et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: